Bioretec Ltd seeks €5M–15M via rights issue by March 27, 2026, with major shareholder backing and up to 12% share dilution.

Bioretec Ltd plans a rights issue to raise €5 million to €15 million by issuing up to 1.5 billion new shares, aiming to strengthen its balance sheet and support growth, with shareholder approval needed by March 27, 2026. The largest shareholder, Stephen Industries Inc Oy, has pledged to vote in favor and subscribe for up to €5 million in new shares, including underwriting any unsold portions. The offering, expected in Q2 2026, is subject to regulatory and market conditions. The company also seeks authorization to issue up to 250 million additional shares for incentives, acquisitions, or financial strength, with potential share dilution capped at 12%. The announcement is not for release in the U.S., Canada, Japan, Australia, or other specified jurisdictions.